Redwood City, CA, United States of America

G Leslie Burnett

This inventor holds 12 USPTO granted patents and 26 published patent applications and 5 EPO patents. Top assignees: Revolution Medicines, Inc., Wilmington Trust, National Association, as Agent. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: G Leslie Burnett. Retrieved from https://idiyas.com/inventor/g-leslie-burnett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 26)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 22)

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 43(Granted Patents)

Location History:

San Mateo, CA (US) (2021)
Redwood City, CA (US) (2021 - 2024)

Company Filing History:

11 out of 40

Revolution Medicines, Inc.

patents

1 out of 3

Wilmington Trust, National Association, as Agent

patents

Years Active: 2021-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12544448 - C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors (2026-02-10),

2. 12258366 - Bicyclic heteroaryl compounds and uses thereof (2025-03-25),

3. 12252497 - Ras inhibitors (2025-03-18),

4. 12202845 - Ras inhibitors (2025-01-21),

5. 12187746 - C26-linked rapamycin analogs as mTOR inhibitors (2025-01-07),

6. 12048749 - C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors (2024-07-30),

7. 11739074 - Ras inhibitors (2023-08-29),

8. 11690915 - Ras inhibitors (2023-07-04),

9. 11685749 - C26-linked rapamycin analogs as mTOR inhibitors (2023-06-27),

10. 11364300 - C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors (2022-06-21),

11. 11168102 - Bicyclic heteroaryl compounds and uses thereof (2021-11-09),

12. 10980889 - C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors (2021-04-20),

Title: G Leslie Burnett: Innovator in Pharmaceutical Compounds

Introduction

G Leslie Burnett is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. Her work focuses on developing innovative compounds that have the potential to treat various diseases.

Latest Patents

Among her latest patents is a disclosure on bicyclic heteroaryl compounds and their uses. This patent is directed towards modulators of SOS1, which are crucial in the treatment of diseases. Additionally, she has developed a patent for Ras inhibitors, featuring macrocyclic compounds and pharmaceutical compositions capable of inhibiting Ras proteins. These inventions are particularly relevant in the treatment of cancers.

Career Highlights

G Leslie Burnett is currently associated with Revolution Medicines, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options for patients.

Collaborations

She collaborates with notable colleagues, including Adrian L Gill and James Joseph Cregg, to further enhance the impact of her inventions.

Conclusion

G Leslie Burnett's innovative work in pharmaceutical compounds showcases her dedication to improving healthcare through science. Her contributions are paving the way for new treatments that could benefit many patients in need.

Profile summary based on public USPTO records.